Prescription drug · ANDA
foscarnet sodium NDC 23155-771
Foscarnet sodium 24 mg/mL · Injection, Solution · Intravenous · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 23155-771-31 | 23155077131 | 1 BOTTLE, GLASS in 1 CARTON (23155-771-31) / 250 mL in 1 BOTTLE, GLASSMarketed from Jun 5, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- foscarnet sodium
- Generic name (nonproprietary)
- foscarnet sodium
- Active ingredients
- Foscarnet sodium — 24 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213807
- Marketing start
- Listing expires
- Other FDA classes
- Chelating Activity (Mechanism)DNA Polymerase Inhibitors (Mechanism)Pyrophosphate Analog (EXT)
- Identifiers
- Product ID 23155-771_7de2fbfd-a1c3-4320-8212-bfeeff0a20a4SPL ID 7de2fbfd-a1c3-4320-8212-bfeeff0a20a4SPL set ID d2b4ce68-5a81-4b14-8914-21bc38f01008RxCUI 1734377UNII 964YS0OOG1UPC 0323155771312
- Pharmacologic class
- Pyrophosphate Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N423155077131followed by a unit qualifier and the quantityPackage 23155-0771-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS CMV Retinitis Foscarnet sodium injection is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Combination therapy with foscarnet sodium and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug. SAFETY AND EFFICACY OF FOSCARNET SODIUM INJETION HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER CMV INFECTIONS (e.g., PNEUMONITIS, GASTROENTERITIS); CONGENITAL OR NEONATAL CMV DISEASE; OR NONIMMUNOCOMPROMISED INDIVIDUALS. Mucocutaneous Acyclovir Resistant HSV Infections Foscarnet sodium injection is indicated for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromis…
Excerpt only. Read the full label for complete information.